Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples